R53.0 — Neoplastic (malignant) related fatigue
Is R53.0 billable?
Yes — R53.0 is billable for FY2027. R53.0 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. R53.0 may be submitted for encounters from October 1, 2026 through September 30, 2027.
R53.0 at a glance
| Code | R53.0 |
|---|---|
| Description | Neoplastic (malignant) related fatigue |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does R53.0 group to?
R53.0 sits in MDC 23 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 947Signs and Symptoms with MCCmedical
- 948Signs and Symptoms without MCCmedical
How is R53.0 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to R53.0. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Fatigue › neoplasm-related
Code first
The underlying condition below must be sequenced before R53.0. R53.0 describes a manifestation and cannot be the principal or first-listed diagnosis.
- associated neoplasm
Excludes2 — not included here — inherited from Chapter 18
The conditions below are not part of R53.0, but a patient may have both at the same time. When documentation supports it, R53.0 and the excluded code may both be reported.
How long has R53.0 existed?
R53.0 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.